Immune Evasion and Resistance in Cancer Progression: Overcoming Checkpoint Inhibition Challenges With Personalized Immunotherapy Guided by PD-L1 Expression. J. Anal. Oncol. 2025, 14, 49-61. https://doi.org/10.30683/1927-7229.2025.14.09.